Andrey E. Shchekotikhin

Dr. Andrey E. Shchekotikhin

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RPRobert A Pearlstein
Robert A Pearlstein
RVRoy J Vaz
Roy J Vaz
JKJiesheng Kang
Jiesheng Kang
XCXiao-Liang Chen
Xiao-Liang Chen
MPMaria Preobrazhenskaya
Maria Preobrazhenskaya
DRDavid Rampe
David Rampe

1 July 2024 in Russian Chemical Reviews
Verified
Journal Article
Closed access
Valery N. CharushinValery N. Charushin
Valery N. Charushin
EVEgor Verbitskiy
Egor Verbitskiy
OCOleg N. Chupakhin
Oleg N. Chupakhin
DVD. V. Vorobyeva
D. V. Vorobyeva
PGPavel S. Gribanov
Pavel S. Gribanov
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov
The chemistry of heterocyclic compounds has traditionally been and remains a bright area of chemical science in Russia. This is due to the fact that many heterocycles find the widest application. These compounds are the key structural fragments of most drugs, plant protection agents. Many natural compounds are also derivatives of heterocycles. At present, more than half of the hundreds of millions of known chemical compounds are heterocycles. This collective review is devoted to the achievements of Russian chemists in this field over the last 15–20 years. The review presents the achievements of leading heterocyclists representing both RAS institutes and university science. It is worth noting the wide scope of the review, both in terms of the geography of author teams, covering the whole of our large country, and in terms of the diversity of research areas. Practically all major types of heterocycles are represented in the review. The special attention is focused on the practical applications of heterocycles in the design of new drugs and biologically active compounds, high-energy molecules, materials for organic electronics and photovoltaics, new ligands for coordination chemistry, and many other rapidly developing areas. These practical advances would not be possible without the development of new fundamental transformations in heterocyclic chemistry. Bibliography — 2237 references.

10 July 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SCSusanna Cogoi
Susanna Cogoi
ASAndrey E. Shchekotikhin
Andrey E. Shchekotikhin
LXLuigi Xodo
Luigi Xodo
The HRAS promoter contains immediately upstream of the transcription start site two neighboring G-elements, each capable of folding into a G-quadruplex structure. We have previously found that these G-quadruplexes bind to the zinc-finger transcription factors MAZ and Sp1. In the present study we have examined the interaction between the HRAS promoter and MAZ, demonstrating for the first time that the protein unfolds the G-quadruplex structures. We also demonstrate that MAZ-GST, in the presence of the complementary strands, promotes a rapid transformation of the two HRAS quadruplexes into duplexes. By a mutational analysis of the HRAS G-elements, we dissected the MAZ-binding sites from the quadruplex-forming motifs, finding that the two neighboring G-quadruplexes bring about a dramatic repression of transcription, in a synergistic manner. We also discovered that the two G-quadruplexes are strong targets for small anticancer molecules. We found that a cell-penetrating anthratiophenedione (ATPD-1), which binds tightly to the G-quadruplexes (ΔT > 15°C), promotes the total extinction of HRAS transcription. In contrast, when one of the two G-quadruplexes was abrogated by point mutations, ATPD-1 repressed transcription by only 50%. Our study provides relevant information for the rationale design of targeted therapy drugs specific for the HRAS oncogene.

1 December 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GMGiulia Miglietta
Giulia Miglietta
SCSusanna Cogoi
Susanna Cogoi
JMJessica Marinello
Jessica Marinello
GCGiovanni Capranico
Giovanni Capranico
ATAlexander S. Tikhomirov
Alexander S. Tikhomirov
LXLuigi Xodo
Luigi Xodo

11 May 2018 in Recent Patents on Anti-Cancer Drug Discovery
Verified
Journal Article
Closed access
PDF file
ATAlexander S. Tikhomirov
Alexander S. Tikhomirov
ASAlexander A. Shtil
Alexander A. Shtil
ASAndrey E. Shchekotikhin
Andrey E. Shchekotikhin
Background: The anthracene-9,10-dione (anthraquinone) derivatives represent an exceptionally valuable class in anticancer drug development. An outstanding antitumor potency of the anthracycline antibiotics attracted the attention of medicinal chemists since the discovery of these chemotypes. The prominent anthraquinone-based drugs doxorubicin, mitoxantrone as well as more recent epirubicin, idarubicin, and valrubicin are successfully used in chemotherapy of hematological malignancies and solid tumors. The anthraquinone core remains a promising scaffold for the search of new optimized drug candidates. Objective: In this study we analyze the progress in discovery and development of antitumor anthracene-9,10-diones based on patent and journal publications in 2008-2017. The main goal is to dissect novel chemotypes of anthraquinone derivatives; other important issues such as the successes in bioconjugate chemistry of anthraquinone containing agents as well as the patents on new applications of anthracyclines are beyond the scope of this review. Conclusion: A number of newly discovered natural products, the perspective directions for chemical modifications to optimize the anticancer properties, and novel intracellular targets demonstrate that anthracene-9,10-diones deserve further in-depth investigation as an important source of drug candidates.

1 February 2018 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
AKA. I. Konovalov
A. I. Konovalov
IAIgor S Antipin
Igor S Antipin
VBV. A. Burilov
V. A. Burilov
TMTimur Madzhidov
Timur Madzhidov
AKA. R. Kurbangalieva
A. R. Kurbangalieva
DKD. N. Kuznetsov
D. N. Kuznetsov
This review is devoted to the scientific achievements of the departments of organic chemistry in higher schools of Russia within the past decade.